Jeevan Scientific Peer Comparison

BSE: 538837

₹81.01

₹-0.75 (-0.92%)

As on 29-Oct-2026IST

Market cap

₹163 Cr

Revenue (TTM)

₹71 Cr

P/E Ratio

46.7

P/B Ratio

2.2

Div. Yield

0 %

Edit

	Jeevan Scientific	Vimta Labs	Genesis IBRC India	Anthem Biosciences	Global Health
Market cap (₹ Cr)	163	2,327	657	46,829	34,933
Revenue (₹ Cr)	71	419	--	2,002	4,683
Net Profit (₹ Cr)	5.14	79.66	-0.86	575.95	552.34
Net Margin (%)	7.16	18.53	-2,391.67	26.66	11.55
RoE (%)	5.85	18.52	-3.56	20.48	14.93
Price to Earnings	46.65	29.22	--	81.31	62.81
Price-To-Book	2.23	4.95	3.45	14.96	8.50

Income Statement (₹ Cr)

	Jeevan Scientific	Vimta Labs	Genesis IBRC India	Anthem Biosciences	Global Health
Operating Revenue	71.02	418.80	0.00	2,002.34	4,683.37
Total Income	71.83	429.85	0.04	2,160.20	4,783.78
Total Expenditure	56.46	273.66	0.87	1,209.46	3,704.62
EBITDA	14.55	145.14	-0.87	792.89	978.75
Depreciation	6.61	46.46	0.02	137.61	246.41
EBIT	7.95	98.68	-0.90	655.28	732.34
Interest	1.94	1.09	0.00	6.17	92.01
Other Income	0.81	11.05	0.04	157.86	100.41
Exceptional Items	0.00	-1.62	0.00	-24.39	-20.61
Profit before Tax	6.82	107.03	-0.86	782.58	720.14
Provision for Tax	1.68	27.37	0.00	206.63	167.80
Profit after Tax	5.14	79.66	-0.86	575.95	552.34

	Jeevan Scientific	Vimta Labs	Genesis IBRC India	Anthem Biosciences	Global Health
Shareholder's Funds	71.94	456.87	40.07	3,042.52	3,961.57
Minority Interest	-1.63	0.00	0.00	0.00	3.84
Non-Current Liabilities	13.74	39.83	0.00	61.06	1,293.60
Current Liabilities	19.89	65.52	5.24	325.71	627.13
Total Liabilities	78.29	466.53	8.84	2,966.58	4,766.23

	Jeevan Scientific	Vimta Labs	Genesis IBRC India	Anthem Biosciences	Global Health
Non-Current Assets	40.19	329.41	0.00	1,421.55	3,128.95
Current Assets	49.87	224.87	45.31	1,803.15	1,674.92
Total Assets	78.29	466.53	8.84	2,966.58	4,766.23
Total Debt*	15.14	8.52	0.00	108.96	327.88
Net Current Assets	29.98	159.35	40.07	1,477.43	1,047.79
Contingent Liabilities	--	2.74	--	54.44	88.77

	Jeevan Scientific	Vimta Labs	Genesis IBRC India	Anthem Biosciences	Global Health
Cash From Operating Activities	10.07	94.05	0.00	270.55	623.76
Cash Flow from Investing Activities	-15.62	-75.54	--	-146.56	-720.94
Cash from Financing Activities	5.24	-16.12	--	-135.65	-97.23
Net Cash Inflow / Outflow	-0.30	2.40	0.00	-11.66	-194.41

	Jeevan Scientific	Vimta Labs	Genesis IBRC India	Anthem Biosciences	Global Health
ROCE (%)	3.17	25.23	51.69	28.55	20.50
ROE (%)	5.85	18.52	-3.56	20.48	14.93
ROA (%)	5.56	15.49	-3.18	33.59	10.35
EBIT Margin (%)	11.19	23.56	--	32.73	15.64
Net Margin (%)	7.16	18.53	-2,391.67	26.66	11.55
Cash Profit Margin (%)	0.00	0.00	--	0.00	0.00

	Jeevan Scientific	Vimta Labs	Genesis IBRC India	Anthem Biosciences	Global Health
Revenue Growth (%)	61.33	14.22	--	-2.14	21.27
EBIT Growth (%)	393.61	6.64	-382.26	1.71	0.94
Net Profit Growth (%)	330.83	11.04	-124.73	14.12	3.43
EPS Growth (%)	235.44	-35.38	-119.33	17.10	2.70
Book Value Growth (%)	1.09	21.06	69.71	23.43	16.71

	Jeevan Scientific	Vimta Labs	Genesis IBRC India	Anthem Biosciences	Global Health
Price / Earnings	42.12	28.73	-64.76	78.71	61.00
Price / Book Value	2.23	4.95	3.81	14.96	8.50
Dividend Yield (%)	0.00	0.38	0.00	0.24	0.04
EV/EBITDA	12.20	15.60	-752.05	57.94	35.18
Market Cap (₹ Cr)	63.50	2,223.71	--	0.00	32,181.74

	Jeevan Scientific	Vimta Labs	Genesis IBRC India	Anthem Biosciences	Global Health
Debt to Equity	0.14	0.00	0.00	0.01	0.15
Short term debt to equity ratio	0.02	--	--	0.02	--
Current Ratio	2.51	3.43	8.64	5.54	2.67
Quick Ratio	2.35	2.97	8.64	5.15	2.54
Interest Coverage	4.51	99.28	--	127.84	8.83

	Jeevan Scientific	Vimta Labs	Genesis IBRC India	Anthem Biosciences	Global Health
Debtors to sales (%)	29.14	25.24	--	29.49	8.78
Asset Turnover	0.77	0.81	0.00	1.17	0.88
Receivable days	110.00	102.52	--	92.78	25.07
Inventory Days	10.55	26.39	--	54.41	6.62
Payable days	255.53	--	--	51.72	79.17
Cash Conversion Cycle	-134.98	--	--	95.47	-47.48

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.